Navigation Links
China Pharma Holdings, Inc. Reports Third Quarter 2013 Financial Results
Date:11/15/2013

HAIKOU, China, Nov. 15, 2013 /PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma", the "Company" or "we"), a NYSE MKT listed corporation with its fully-integrated specialty pharmaceutical subsidiary based in China, today announced financial results for the three months ended September 30, 2013.

Third Quarter Highlights

  • Revenue decreased 33% to $8.1 million in the third quarter of 2013 from $12.2 million in the third quarter of 2012.
  • Gross profit was $2.2 million in the third quarter of 2013, a decrease of approximately $1.0 million compared to $3.2 million gross profit in the third quarter of 2012.
  • Net loss was $2.3 million in the third quarter of 2013 compared to $1.3 million net income in the third quarter of 2012, a decrease of $3.6 million. Earnings (loss) per common share was ($0.05) per basic and diluted share in the third quarter of 2013 compared with $0.03 per share in the same period last year.
  • Candesartan, a front-line drug therapy for the treatment of hypertension, was launched in November, 2013 and we expect this product to generate revenue in the fourth quarter of 2013.
  • Our "National High-Tech Enterprise" status ("National HT Status") was successfully renewed in the third quarter of 2013. With this designation, we continue to be entitled to a preferential tax rate of 15% for the years ending December 31, 2014, 2015 and 2016, which is notably lower than the statutory income tax rate of 25%.
  • "We feel excited about the launching of Candesartan, the long-awaited front-line drug therapy for the treatment of hypertension in November, 2013. We expect this product to bring positive impact on our revenue and margin through organized marketing and our existing sales network. " Ms. Zhilin Li, China Pharma's Chairman and CEO continued. "The successful renewal of National HT Status, which entitles us to a preferential tax rate of 15% for 2014, 2015 and 2016, require
    '/>"/>

    SOURCE China Pharma Holdings, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. China Jo-Jo Drugstores Announces Fiscal 2014 Second Quarter Financial Results
    2. China Jo-Jo Drugstores Announces Second Quarter Fiscal 2014 Conference Call
    3. NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement
    4. 2013 China Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Report
    5. 2013 Deep Research Report on Global and China Vitamin H Industry
    6. 2012 Deep Research Report on Global and China Plastic Injection Molding Machine Industry
    7. China Nepstar Chain Drugstore to Report Third Quarter 2013 Financial Results on November 26, 2013
    8. China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2013
    9. Governor-General of Australia Ms. Bryce Visits Sichuan University and Investigates Australia Cochlear Cochlea Project in West China Hospital, Sichuan University
    10. The Medical Device Market: China
    11. China Biologic Products to Report Third Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/22/2014)... Mass. , Sept. 22, 2014  Seres Health, ... related to the human microbiome, today announced that it ... of 2014,s Fierce 15 biotechnology companies, designating it as ... the industry.  "Amid a great deal ... for its focus and commitment to practical therapeutic development," ...
    (Date:9/22/2014)... PLEASANTON, Calif. , Sept. 22, 2014 ... leader in device-based mechanical circulatory support therapies to save, ... D. Keith Grossman has been appointed President and ... F. Burbach , who has stepped down from his ... advisor to the company through the first quarter of ...
    (Date:9/22/2014)... cancer is the second leading cause of cancer death ... early - the problem is that too often it ... Education Council (PCEC), – a national organization committed ... screening –  is sponsoring its 25 th Annual ... Committed to encouraging men to take a ...
    Breaking Medicine Technology:Seres Health Named a "Fierce 15" Biotech Company for 2014 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 2PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 3
    ... -- Concord Medical Services Holdings Limited ("Concord Medical" or ... of the largest network of radiotherapy and diagnostic imaging ... directors approved a share repurchase program, effective immediately. ... States federal securities laws, Concord Medical is authorized to ...
    ... Sept. 29, 2011 The Educational Review System held ... 28 at the Meyedenbauer Center in Bellevue, WA. Attendees ... pharmacy thought leaders discuss the challenges of pediatric medications, ... the 2010 recipient of the Institute for Safe Medication ...
    Cached Medicine Technology:Concord Medical Services Announces Share Repurchase Program 2Concord Medical Services Announces Share Repurchase Program 3
    (Date:9/22/2014)... surprising new study pulls back the curtain on one ... in payment and income between physicians who perform operations, ... Contrary to perception, the research indicates, the physician payment ... other procedure-performing doctors. , The new findings counter the ... per minute explains why doctors who perform procedures often ...
    (Date:9/22/2014)... Norton HealthDay Reporter MONDAY, ... better when newborn intensive care units (NICU) set up private ... new study finds. Researchers at one children,s hospital found ... less distressed when their NICU switched from the traditional "open-bay" ... online Sept. 22 in the journal Pediatrics , add ...
    (Date:9/22/2014)... of patients undergoing breast cancer surgery require additional operations ... tissue in the initial operation. However, researchers at Brigham ... they developed that will help surgeons better distinguish cancerous ... for repeat operations. , The study ... in the Proceedings of the National Academy of ...
    (Date:9/22/2014)... (September 22, 2014) McMaster scientists have found that ... class of antibiotics. , Although dozens of antibiotics ... how a certain part of bacteria are created, and ... , The discovery is important as there is ... the cures for infections ineffective. The World Health Organization ...
    (Date:9/22/2014)... This Flash Report is a top-line view ... the Prostate Cancer market. , Download the flash report ... any launching Prostate Cancer product:, ... crowded market , Understanding stakeholder interactions with ... thought leaders and stakeholders ,Download the white paper ...
    Breaking Medicine News(10 mins):Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:The fine line between breast cancer and normal tissues 2Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2
    ... engineer has developed a technique which uses plastidial transformation ... (HSA) from tobacco plants. HSA is an intravenous protein ... ,It is mainly used to stabilize blood ... is used for haemorrhages, burns, surgical operations or when ...
    ... Veterinary schools in sub-Saharan Africa have joined forces ... allow vets to study// for postgraduate degrees while ... Veterinary E-Learning Consortium, launched in early March, will ... full-time degrees, reported the SciDev.net science-for-development network. ...
    ... Conference (EBCC-5) have called that patients should have speedy access ... Doctors and patient groups said that women in Europe are ... could help prolong their survival and well being. ... are available to women in the United States far more ...
    ... Quest? cigarettes seems to have lulled smokers into a ... by researchers// at the Transdisciplinary Tobacco Use Research Center ... the study have been published in the journal Psychology ... study, Caryn Lerman, PhD, Associate Director for Cancer Control ...
    ... revealed that Africa's TB crisis has its origin in HIV/AIDS, ... two million people who die from TB every year, 1.5 ... the African Medical and Research Foundation (AMREF) clinic in the ... to TB were also infected with HIV. According to Nzioka, ...
    ... According to studies done at the Yale school of medicine, ... we get when we eat certain foodstuffs//, like garlic, mustard ... receptor they ay also underlines the reaction of the body ... vehicle exhaust and byproducts of certain chemo receptor drugs used ...
    Cached Medicine News:Health News:Alternate ways to produce HAS from tobacco plants 2
    For injecting viscoelastic to all meridians of the anterior chamber and to coat intraocular lenses. 20G x 7.8in (.90 x 22mm)....
    For administering anesthetic agents into the posterior sub-Tenon's space 20G x 1in (.90 x 25mm)...
    ... is the most versatile diagnostic tool in ... solutions for glaucoma, diabetic retinopathy, age-related macular ... RTA is the only system in the ... pole and the optic nerve areas in ...
    Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
    Medicine Products: